Download PDF
Arzneimittelforschung 2010; 60(10): 587-592
DOI: 10.1055/s-0031-1296330
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Synthesis and antidepressant-like action of 9-alkoxy-7H-furo[3,2-g]chromen-7-ones in mice

Xian-Qing Deng
1   College of Pharmacy, Yanbian University, Yanji, Jilin, P. R. China
,
Cheng-Xi Wei
1   College of Pharmacy, Yanbian University, Yanji, Jilin, P. R. China
2   Institute of Neurosurgery, Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia Autonomous Region, P. R. China
,
Ming-Xia Song
1   College of Pharmacy, Yanbian University, Yanji, Jilin, P. R. China
,
Zhe-Shan Quan
1   College of Pharmacy, Yanbian University, Yanji, Jilin, P. R. China
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

   Permissions and Reprints

Abstract

The present study describes the chemical synthesis and pharmacological evaluation of a series of 9-alkoxy-7H-furo[3,2-g]-chromen-7-ones. The pharmacological results of these compounds show that nine of them, given orally, reduced the immobility time in the forced swimming test. The results of the open-field test further confirmed that these compounds possessed an antidepressant-like effect. In the 5-hydroxytryptophan induced head-twitch test, 9-(3-chlorobenzyloxy)-7H-furo[3,2-g]chromen-7-one (3m, 40 mg/kg p. o.) significantly increased the cumulative number of head twitches. This finding suggested that the antidepressant-like profile seems to involve the serotonergic system as underlying mechanism.

Key words

Antidepressant - Forced swimming test - Furocoumarin - 5-Hydroxytryptophan - Open-field test - Psoralen, analogues
 

  • References

  • 1 Meyer C. Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health. 2004; 7: 123-7
    CrossrefPubMedSearch in Google Scholar
  • 2 Lopez AD, Murray CC. The global burden of disease, 1990–2020. Nat Med. 1998:4:1241–3.
    PubMed
  • 3 Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry. 2003; 64 (13) 18-25
    PubMedSearch in Google Scholar
  • 4 Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM et al. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. J Clin Psychiatry. 2007; 68: 224-36
    CrossrefPubMedSearch in Google Scholar
  • 5 Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry. 1999; 60: 326-35
    CrossrefPubMedSearch in Google Scholar
  • 6 Liu ZL, Zhang XN, Zhao SJ, Zhou RX. Extraction and purification of psoralen from Psoralea corylifolia L.. Di Yi, Jun YI, Da Xue, Xue Bao. 2005. 25. 751-2
    Search in Google Scholar
  • 7 Kuete V, Metuno R, Ngameni B, Tsafack AM, Ngandeu F, Fotso GW et al. Antimicrobial activity of the methanolic extracts and compounds from Treculia obovoidea (Moraceae). J Ethnopharmacol. 2007; 112: 531-6
    CrossrefPubMedSearch in Google Scholar
  • 8 Eun JS, Kim KS, Kim HN, Park SA, Ma TZ, Lee KA et al. Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel. Arch Pharm Res. 2007; 30: 155-60
    CrossrefPubMedSearch in Google Scholar
  • 9 Wu CR, Chang CL, Hsieh PY, Lin LW, Ching H. Psoralen and isopsoralen, two coumarins of Psoraleae Fructus, can alleviate scopolamine-induced amnesia in rats. Planta Med. 2007; 73 (3) 275-8
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Wang Y, Hong C, Zhou C, Xu D, Qu HB, Cheng Y. Screening antitumor compounds psoralen and isopsoralen from psoralea corylifolia L. Seeds. Evid Based Complement Alternat Med. 2009 Jan 8. [Epub ahead of print]
    PubMedSearch in Google Scholar
  • 11 Chen Y, Kong LD, Xia X, Kung HF, Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J Ethnopharmacol. 2005; 96: 451-9
    CrossrefPubMedSearch in Google Scholar
  • 12 Xu Q, Pan Y, Yi LT, Li YC, Mo SF, Jiang FX et al. Antidepressant-like effects of psoralen isolated from the seeds of Psoralea corylifolia in the mouse forced swimming test. Biol Pharm Bull. 2008; 31: 1109-14
    CrossrefPubMedSearch in Google Scholar
  • 13 Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 435-51
    CrossrefPubMedSearch in Google Scholar
  • 14 Millan MJ. The role of monamines in the actions of established and “novel” antidepressant agents: a critical review. Eur J Pharmacol. 2004; 500: 371-84
    CrossrefPubMedSearch in Google Scholar
  • 15 Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977; 229: 327-36
    PubMedSearch in Google Scholar
  • 16 Hanna MM, Eida NM, Georgea RF, Safwat HM. Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin. Bioorg Med Chem. 2007; 15: 7765-72
    CrossrefPubMedSearch in Google Scholar
  • 17 Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002; 23: 238-45
    CrossrefPubMedSearch in Google Scholar
  • 18 Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev. 2005; 29: 547-69
    CrossrefPubMedSearch in Google Scholar
  • 19 Bourin M, Chenu F, Ripoll N, David DJ. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res. 2005; 164: 266-9
    CrossrefPubMedSearch in Google Scholar
  • 20 Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.). 2005; 177: 245-55
    CrossrefPubMedSearch in Google Scholar
  • 21 Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 435-351
    CrossrefPubMedSearch in Google Scholar
  • 22 Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE et al. Innovative approaches for the development of antidepressant drugs: current and future strategies. Neuro Rx. 2005; 2: 590-611
    CrossrefPubMedSearch in Google Scholar
  • 23 Richelson E. The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors. Psychopharmacol Bull. 2002; 36: 133-50
    PubMedSearch in Google Scholar
  • 24 Corne SJ, Pickering RW, Warner BT. A method for assessing the effects of drugs on the central actions of 5-hydroxy-tryptamine. Br J Pharmacol Chemother. 1963; 20: 106-20
    CrossrefPubMedSearch in Google Scholar
  • 25 Lapin IP. Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs. Psychopharmacology. 1980; 70: 179-85
    CrossrefPubMedSearch in Google Scholar
  • 26 Luo ZP. Anti-depressive pharmacology. Beijing People’s Medical Publishing House; 2005
    Search in Google Scholar